Iterum Therapeutics US Holding Ltd — Form D

Iterum Therapeutics US Holding Ltd of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-31. The offering totals $51.6M, of which $51.6M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (16)

NameRoleLocation
Brenton K AhrensDirectorDublin, L2
Louise M BarrettDirectorDublin, L2
Mark I ChinDirectorDublin, L2
Corey N FishmanDirectorDublin, L2
James I HealyDirectorDORADO, PR
Patrick J HeronDirectorMenlo Park, CA
Ronald M HuntDirectorNew York, NY
David M KellyDirectorWestfield, MA
Shahzad M MalikDirectorDublin, L2
Judith M MatthewsDirectorDublin, L2
Michael M DunneExecutive OfficerDublin, L2
Corey N FishmanExecutive OfficerDublin, L2
Judith M MatthewsExecutive OfficerDublin, L2
Michael M DunnePromoterDublin, L2
Corey N FishmanPromoterDublin, L2
Judith M MatthewsPromoterDublin, L2

More